Related Experiment Video
Updated: Oct 20, 2025
07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
664
Protease Activated Receptors and Arthritis
Flora Lucena1, Jason J McDougall1
1Departments of Pharmacology and Anesthesia, Pain Management & Perioperative Medicine, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada.
International Journal of Molecular Sciences
|September 10, 2021
Summary
Serine proteases in joints signal pain and inflammation by activating protease-activated receptors (PARs). Targeting these PARs offers therapeutic potential for arthritis by modulating pain and joint destruction.
Area of Science:
- Biochemistry
- Molecular Biology
- Rheumatology
Background:
- Serine proteases contribute to joint destruction in arthritis.
- These enzymes also play a role in signaling pain and inflammation within joints.
Purpose of the Study:
- To review the role of protease-activated receptors (PARs) in arthritic joints.
- To highlight the therapeutic potential of targeting PARs for arthritis treatment.
Main Methods:
- Review of existing literature on serine proteases and PARs in joint disease.
- Analysis of signaling pathways initiated by protease cleavage of PARs.
- Examination of PAR involvement in vascular reactivity, nociceptor sensitivity, and tissue remodeling.
Main Results:
- Protease-activated receptors (PARs) are activated by serine proteases (thrombin, trypsin, tryptase, neutrophil elastase) in arthritic joints.
- Activated PARs initiate molecular signaling cascades that influence joint homeostasis.
- PARs contribute to joint pain, inflammation, and structural damage through vascular, neuronal, and tissue remodeling effects.
Conclusions:
- Protease-activated receptors (PARs) are key mediators of pain and inflammation in arthritis.
- Targeting PARs presents a promising therapeutic strategy to manage pain and reduce joint destruction in arthritic conditions.
Related Concept Videos
01:24T Cell Types and Functions
1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
01:20The JAK-STAT Signaling Pathway
9.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.6K
01:00Enzyme-linked Receptors
80.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.2K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.2K
01:11Genome-wide Association Studies-GWAS
14.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.7K
01:12GPCR Desensitization
6.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.8K